nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ALKBH1 promotes lung cancer by regulating m6A RNA demethylation
|
Li, Hong |
|
|
189 |
C |
p. |
artikel |
2 |
A nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy
|
Sun, Min |
|
|
189 |
C |
p. |
artikel |
3 |
A novel mechanism underlying alcohol dehydrogenase expression: hsa-miR-148a-3p promotes ADH4 expression via an AGO1-dependent manner in control and ethanol-exposed hepatic cells
|
Luo, Jiao |
|
|
189 |
C |
p. |
artikel |
4 |
Antisense drug discovery and development technology considered in a pharmacological context
|
Crooke, Stanley T. |
|
|
189 |
C |
p. |
artikel |
5 |
Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics
|
Zeng, Li |
|
|
189 |
C |
p. |
artikel |
6 |
Editorial Board
|
|
|
|
189 |
C |
p. |
artikel |
7 |
Flavonoid display ability to target microRNAs in cancer pathogenesis
|
Singh, Shilpi |
|
|
189 |
C |
p. |
artikel |
8 |
Identification of microRNAs that promote erlotinib resistance in non-small cell lung cancer
|
Pal, A.S. |
|
|
189 |
C |
p. |
artikel |
9 |
LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance
|
Zhou, Ying |
|
|
189 |
C |
p. |
artikel |
10 |
Metformin-conjugated micellar system with intratumoral pH responsive de-shielding for co-delivery of doxorubicin and nucleic acid
|
Liu, Yanhua |
|
|
189 |
C |
p. |
artikel |
11 |
MicroRNA-101 inhibits cadmium-induced angiogenesis by targeting cyclooxygenase-2 in primary human umbilical vein endothelial cells
|
Che, Lin |
|
|
189 |
C |
p. |
artikel |
12 |
MicroRNAs in diabetic nephropathy: From molecular mechanisms to new therapeutic targets of treatment
|
Yarahmadi, Amir |
|
|
189 |
C |
p. |
artikel |
13 |
MiRNAs directly targeting the key intermediates of biological pathways in pancreatic cancer
|
Sarwar, Ammar |
|
|
189 |
C |
p. |
artikel |
14 |
Non-coding RNAs: Emerging from the discovery to therapeutic applications
|
Baptista, B. |
|
|
189 |
C |
p. |
artikel |
15 |
Nucleic acids therapeutics using PolyPurine Reverse Hoogsteen hairpins
|
Noé, Véronique |
|
|
189 |
C |
p. |
artikel |
16 |
Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges
|
Fairman, Kiara |
|
|
189 |
C |
p. |
artikel |
17 |
Prolonged cultured human hepatocytes as an in vitro experimental system for the evaluation of potency and duration of activity of RNA therapeutics: Demonstration of prolonged duration of gene silencing effects of a GalNAc-conjugated human hypoxanthine phosphoribosyl transferase (HPRT1) siRNA
|
Yang, Qian |
|
|
189 |
C |
p. |
artikel |
18 |
Recognition of nucleolin through interaction with RNA G-quadruplex
|
Santos, Tiago |
|
|
189 |
C |
p. |
artikel |
19 |
RNA therapeutics: From biochemical pharmacology to technology development and clinical applications
|
Ning, Baitang |
|
|
189 |
C |
p. |
artikel |
20 |
S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine
|
Li, Ting |
|
|
189 |
C |
p. |
artikel |
21 |
Single bioengineered ncRNA molecule for dual-targeting toward the control of non-small cell lung cancer patient-derived xenograft tumor growth
|
Petrek, Hannah |
|
|
189 |
C |
p. |
artikel |
22 |
Small nucleic acids and the path to the clinic for anti-CRISPR
|
Barkau, Christopher L. |
|
|
189 |
C |
p. |
artikel |
23 |
Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer
|
Huang, Chengzhi |
|
|
189 |
C |
p. |
artikel |
24 |
Targeting Akt-associated microRNAs for cancer therapeutics
|
Adil, Mir S. |
|
|
189 |
C |
p. |
artikel |
25 |
Targeting nucleolin by RNA G-quadruplex-forming motif
|
Figueiredo, Joana |
|
|
189 |
C |
p. |
artikel |
26 |
Targeting the spliceosome machinery: A new therapeutic axis in cancer?
|
Eymin, Beatrice |
|
|
189 |
C |
p. |
artikel |
27 |
The growth of siRNA-based therapeutics: Updated clinical studies
|
Zhang, M. May |
|
|
189 |
C |
p. |
artikel |
28 |
The N 6-methyladenosine modification posttranscriptionally regulates hepatic UGT2B7 expression
|
Ondo, Kyoko |
|
|
189 |
C |
p. |
artikel |
29 |
TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer
|
Tan, Ying |
|
|
189 |
C |
p. |
artikel |